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ABSTRACT
Objective: The objective of the present study is to assess the antibacterial properties of six indole derivatives viz, 3-(Naphth-1-y - methyl) –indole
(II), 3-(1-Naphthylcarbonyl – indole (III), 3,3' –diformyl-2,2' –bis indole (IV), 1,4- (3,3' –di indolyl) – 1,4-dioxobutane (V), 3-benzoyl indole (VI) and
1,1 – bis – (3-indolyl)- ethane (VII) synthesized by single electron transfer reduction of 3-formylindole (I) against two Gram +ve and two Gram –ve
bacteria which usually cause human infections.
Methods: Synthesis of 3-formyl indole from which the indole derivatives were prepared were further characterized by IR and NMR analysis. The six
synthesized compounds were screened for their antibacterial activity by agar diffusion method and the activities were further confirmed by
determining their MIC values by microdilution technique.
Results: All of the compounds more or less showed activity against different bacterial species except compound IV which showed activity only
against B. subtilis. Compound II exhibited the most potent activity with lower MIC values against two Gram –ve and one Gram +ve bacteria of which
the Gram –ve ones are known to be responsible for nosocomial and community acquired infections.
Conclusion: Compound II being the most potent active compound may serve as leads for further optimization most likely to contribute as a broad
spectrum antibiotic.
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INTRODUCTION

MATERIAIS AND METHODS

Antimicrobial resistance is growing quickly throughout the world
due to extensive and indiscriminate use of antibiotics [1].
Development of new class of antibacterial agent with different mode
of action is urgently needed to combat this problem. Several
pharmaceutical companies intensified their efforts in search for new
class of antibacterial agents which resulted in a spectacular
advancement in medicinal chemistry.

Chemistry

Reduction of indole derivatives comprises a very important and
interesting branch of synthetic organic chemistry as these
reactions are utilized in the synthesis of several drugs, dyes,
agrochemicals and higher alkaloids. Since the nitrogen
heterocycles are of great importance in chemistry and biology,
the reduction of these compounds are of vital importance.
Synthesized heterocyclic compounds like 3-heterosubstituted
indoles, oxindoles and benzimidazole derivatives have attracted
considerable interest because of their various biological
applications [2,3,4].The reluctance of synthesizing biologically
active indole derivatives is explicable in terms of highly
electron-rich system of the indole ring, which has little tendency
to accept an electron. The tendency to form an indolyl radical
anion by accepting an electron can be increased by introducing
an electron-withdrawing substituent at C-3 of the indole ring. As
a part of our investigation in this field we have recently reported
[5] the synthesis of indolo[2,3-a]carbazoles based on the
reaction between (I) and sodium naphthalenide using the
product (IV) as the key intermediate (Scheme 1). Indolo[2,3a]carbazoles can frequently serve as a nucleus of various
medicinal important natural products e. g. staurosporine [6],
rebeccamycin [7], K-252a [8], alkaloids [9] e.g. arcyriaflavin A,
AT2433-B aglycone etc.
The effect of sodium naphthalenide (Na NaPh), a cost-effective and
easily available single electron transfer (SET) reagent, on different
3-oxoindoles has been studied. The structural, mechanistic as well as
chemical aspects have already been reported [10,11]. The objective
of the present study is to evaluate the antibacterial activities of some
of the indole derivatives obtained from 3-formyl indole (I) following
a schematic synthetic procedure (Scheme 1).

All the chemicals and solvents used in this experiment were of
analytical grades and procured from Merck (India).
Synthesis of 3-formyl indole 5 ml of phosphoryl chloride (POCl3) was
added dropwise with stirring to N,N dimethyl formamide (16 g) in a
flask protected from atmospheric moisture (temperature is
maintained between 0 – 200C). Indole (5.85 g) was then slowly
added to 4 g of dry DMF (N,N dimethyl formamide) with stirring
(temperature was kept in between 20-300C). The mixture was then
kept at 350C for 45 min. It was neutralized by aqueous sodium
hydroxide solution (9.5 g in 50 ml water) at temperature 20-300C.
Resulting solution was quickly boiled for 1 min. Pale yellow crystals
were obtained, filtered, washed with distilled water and dried in air.
IR spectra were recorded on a Perkin-Elmer FT-IR spectrometer
(Model: Spectrum RX1) using solid KBr. Mass spectra were
performed on JEOL –AX 500 mass spectrometer. NMR spectra were
recorded on a Brooker AV 300 (5 mm probe).
3-formyl indole (I): Yield 86%; m.pt 1980C; Anal. Calcd. for C9H7NO:
C,74.78; H, 4.83; N,9.65; Found: C, 74.58; H, 4.62; N, 9.51; IR (KBr
disc): 3440 cm-1 (N –H str.. of a secondary amine), 3115 cm-1 (C- H
str., hetero aromaticity), 3663 cm-1 and 3045 cm-1 (coupled vibration
with other C- H str.), 2821 cm-1, 2725 cm-1 (C – H str. of formyl
group), 1633 cm-1 (C = O str. in formyl group); 1H NMR (300MHz/
CDCl3): δ 10.1 (1H, s, >NH), 7.55 (1H, s, C2H), 9.73 (1H, s,, -CHO),
8.20,7.19, 7.01, 7.54 (4H, m, Ar<); 13C NMR: δ 138.1, 118.2, 121.3,
119.8, 121.7, 111.1, 126.3, 137.1; MS (70ev) m/z 145 (M+, 62.8%).
The indole derivatives are obtained from 3-formyl indole (I) following
the schematic synthetic procedure as given below (Scheme 1).
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Scheme 1: Synthesis of different indole derivatives (II – VII) from 3-formyl indole (I).
Antibacterial screening
a) Agar well diffusion assay
The antibacterial activity of the compounds (II-VII) was tested
against four bacterial organisms. The test organisms taken were
Bacillus subtilis AR2, Escherichia coli XLI-Blue, Staphylococcus
aureus (MTCC 1430) and Pseudomonas aeruginosa (MTCC 424).
The agar-well diffusion method [12] was used to assess the
bioactivity of the synthesized compounds. B. subtilis and E. coli
were procured from Bose Institute, Kolkata, India whereas
Staphylococcus aureus and Pseudomonas aeruginosa were
procured from Institute of Microbial Technology, Chandigarh,
India. Luria-Bertini agar was used as culture medium for B. subtilis
and E. coli species and nutrient agar was used for the remaining
two species. The test compounds were dissolved in 50% dioxane
(v/v in water) at a concentration of 2 mg/ml. The bacteria were
subcultured in their respective liquid media (LB broth and
nutrient broth) taken in four different Ehrlenmeyer’s flasks of 100
ml capacity containing 50 ml each of sterile media. The flasks were
inoculated with loopful of different bacterial strains and incubated
on a rotary shaker for 18 hrs at 37°C to activate the strains. The
absorbance was read at 530 nm and adjusted with sterile distilled
water to match with that of 0.5 Mc Farland standard solution to
give a final concentration of 1.0 x 10 6 CFU/ml of bacterial cells. 0.1
ml of bacterial suspensions was taken from each flask and
uniformly spread over sterile agar plates by the help of sterilized
glass spreader. The plates were kept in refrigerator for 20 minutes
to allow the test organisms to get fully embedded in the medium.
Then wells (9 mm diameter) were cut out from agar plates using a
sterilized cork borer and they were aseptically filled with 100μl of
respective test compounds (II –VII) with a sterile micropipette.
The plates were again kept in refrigerator for 1hr to allow the test
compounds to diffuse thoroughly into the agar and finally they

were incubated at 37 °C for 48 hrs and the diameter of inhibition
zones (in mm) were noted. Same volume of 50% Dioxane and
Streptomycin at a concentration of 1mg/ml were used to serve as
negative and positive control respectively. All experimental sets
were done with three replicates for each and the mean values of
the zones were calculated as ± SD (Table 1). The activity indices
designated as AI were calculated as the division of zone of
inhibition of the test compounds by that of the standard drug [13].
b) Determination of Minimum Inhibitory Concentration (MIC)
For estimating the MIC of the test compounds micro-dilution
technique [14] was performed(.) 1ml of of each test compounds at
various concentrations ranging from 40 µg/ml to 180µg/ml was
added to 3ml of respective sterile broths and 0.1ml of each
microorganisms (1.0 x 106 CFU/ml) was inoculated into each test
tube and mixed thoroughly. The tubes were incubated at 37°C for
24h hrs and the bacterial turbidity in each test tube was measured at
600nm. Streptomycin (10 µg/ml) was used as reference antibiotic
and tubes containing only growth medium and microorganisms
were used as control. The tubes with lowest dilution showing no
turbidity after 24 hrs incubation was considered as the MIC and the
results were presented in Table 2.
RESULTS
In our experiment the basic compound, 3 – formyl indole (I) has
been synthesized in good yield (86%) , from that other compounds
(II – VII) have been synthesized accordingly (Scheme –1) via known
methods.
The compounds (II – VII) were tested for their antibacterial
activities by agar-well diffusion method and further confirmed by
their MIC values. The results of inhibition (in mm) are shown in
Table 1 and the MIC values are presented in Table 2.

Table 1: Antibacterial activity of different indole derivatives (compounds II-VII) using agar diffusion method (inhibition zones in mm).
Test Samples
II
III
IV
V
VI
VII
Streptomycin (+ve control)

B. subtilis
Z.I.
16 ± 0.2
13 ± 0.3
14 ± 0.6
―
13 ± 0.3
18 ± 0.5
25 ± 0.1

A.I.
0.64
0.52
0.56
―
0.52
0.72
NA

S.aureus
Z.I.
―
―
―
15 ± 0.7
―
―
20 ± 0.1

A.I.
―
―
―
0.75
―
―
NA

E.coli
Z.I.
15 ± 0.2
16 ± 0.3
—
12 ± 0.2
15 ± 0.5
18 ± 0.8
20 ± 0.2

A.I.
0.75
0.80
―
0.60
0.75
0.90
NA

P. aeruginosa
Z.I.
20 ± 0.5
―
―
19 ± 0.7
―
―
18 ± 0.1

A.I.
1.1
―
―
1.1
―
―
NA

Z.I.= zone of inhibition, A.I.= activity index with respect to streptomycin; NA= not applicable;Inhibition zones are mean of three replicates ± SD ; '—'
indicates no inhibition.
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The results from Table 1 clearly indicates that B. subtilis and E. coli
are more or less susceptible against all the compounds (II – VII) in
question whereas S. aureus showed inhibition only against
compound V and P. aeruginosa showed inhibition against

compounds II and V. All the compounds except compound V could
inhibit the growth of B. subtilis. Compound IV showed activity only
against B. subtilis and thus it may be considered as the least potent
bioactive compound amongst the compounds under study.

Table 2: MIC values of indole derivatives (compounds II – VII) against the bacterial species (in μg/ml).
Bacterial Strains
B. subtilis
(Gram + ve)
S. aureus
(Gram + ve)
E. coli
(Gram – ve)
P. aeruginosa
(Gram – ve)

MIC values (μg/ml) of the Indole compounds
II
III
IV
90
180
160

V
--

VI
140

VII
40

--

--

--

140

--

--

70

80

--

180

80

40

100

--

--

100

--

--

DISCUSSION
In the present work, effect of a single electron transfer reagent,
sodium naphthalenide on a 3-oxoindole compound , 3- formyl indole
resulted in production of six different indole derivatives by the
following procedure represented as Scheme I. The compounds II and
III are formed from anion radical (A) derived from coupling of
substrate and naphthalenide radical whereas compound IV is a
simple dimerisation at 2,2' position of radical anion of 3 – formyl
indole. In the formation of Compound VI and Compound VII simple
radical ion mechanism was followed. But for Compound V, radical
dimerisation followed by stepwise removal of fluorine is the
mechanistic pathway. The stepwise defluorination was supported
mechanistically by Stocker et.al. [15]. Spectral data and detail
mechanistic interpretation related to this context have already been
reported else where [10,11].
It is obviously interesting to note that most of the compounds have a
tendency to be more effective against Gram –ve bacteria as revealed
by the comparatively larger dimensions of the inhibitory zones and
in this respect compound II showed the highest efficacy to combat
against two Gram –ve (P. aeruginosa and E. coli) and one Gram +ve
(S. aureus) bacteria. Usually the Gram +ve bacteria are more
susceptible to antibacterial agents than the Gram – ve one [16] and
this is due to the fact that the cell wall of the former possess only a
single peptidoglycan layer whereas the cell wall of the latter possess
a thi peptidoglycan layer. Thus the efficacy of compounds II and V
and to a certain extent compound VII are found quite promising as
antimicrobial agent since they could combat against P. aeruginosa
and S. aureus which are reported to be frequently associated with
nosocomial and community acquired infection [17,18] and E. coli is
very
much
associated
with
common
infections
like
gastroenterititis11. Although the mode of action of these indole
derivatives is not known in detail but some studies have shown that
the presence of electron withdrawing group have shown influence
on bioactivity [19]. Thus the susceptibility of the usually resistant
Gram – ve strains may be correlated to two major reasons. One is the
electronic effect which infers that the presence of electron
withdrawing group withdraw the electron cloud from substituted
indole thus acting as nucleophilic centre which caused high level of
activity as exhibited by the compounds II, III, V and VI. However this
is not true in case of Compound VII where instead of a nucleophilic
centre, it is the substitution of one hydrogen atom of –CH2- by CH3
which caused an increase in the number of carbon atoms thus
enhancing the maximal binding capacity and potency of the
respective compound. The second plausible reason might be that the
compounds being heterocyclic and aromatic in nature (property of
indole derivatives) are strongly hydrophobic which enable them to
partition the lipids of the outer membrane of the Gram – ve bacteria
thus disturbing their cellular integrity and rendering them more
permeable and vulnerable to cellular leakage [20]. Moreover, in
addition to the failure of the outer membrane to act as a barrier to
the penetration of these indole derivatives, the enzymes of the
periplasmic space were also perhaps unable to degrade those
exogenous molecules [21].

The MIC values presented in Table 2 are more or less in conformity
with the results obtained in Table 1. However, the differences in
diameter of inhibitory zones against different microorganisms may
not exactly match with the differences in their corresponding MIC
values as noticed in case of compound II where P. areuginosa
showed higher inhibition zone (20mm) than B. subtilis (16mm) and
E. coli (15mm) whereas the MIC values were found to be greater in
P. areuginosa (100 µg/ml) than those of B. subtilis and E. coli where
inhibition occurred at lower concentrations of 90 µg/ml and
70µg/ml respectively. Such variation in the antibacterial property
could be attributed to certain extrinsic factors like variable
diffusability in agar medium and inoculum size [22] and certain
intrinsic factors like variable permerability of the cell surface of the
microorganisms to the antibacterial compounds and the respective
chemical structure of the antibacterial compound in itself [23].
CONCLUSION
From the above findings the bioactive potency of the synthesized
compounds can be arranged in the following order of decreasing activity:
II > V > VII > VI > III > IV
Moreover, the bacteria like S. aureus, P. aeruginosa and E. coli being
responsible for nosocomial and community acquired infections, a
further investigation of the potent antimicrobial compounds (II, V
and VII) needs to be conducted against a number of such strains
isolated from hospitals or infected patients in which multidrug
resistance might develop along with their mode of action within
these microorganisms in order to prove their antibacterial efficacy.
Compound II being active against both Gram +ve and Gram –ve
pathogenic strains at lower MIC values is likely to contribute as a
broad spectrum antibiotic. Since the compounds are pure they could
be of commercial interest to both pharmaceutical companies and
research institutes in the production of new drugs only after
thorough checking of their toxicity as well as their efficacy in animal
models.
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